Dextromethorphan as an in vivo probe for the simultaneous determination of CYP2D6 and CYP3A activity

Journal of Chromatography B: Biomedical Applications

Volumn 678, Issue 1, 1996, Pages 113-128

  Ducharme, Julie ^a   Abdullah, Sami ^a   Wainer, Irving W ^a  

^a MONTREAL GENERAL HOSPITAL   (Canada)

Author keywords

3 Methoxymorphinan; Cytochromes; Dextromethorphan; Dextrorphan

Indexed keywords

3 METHOXYMORPHINAN; CYTOCHROME P450 ISOENZYME; DEXTROMETHORPHAN; DEXTRORPHAN; DRUG METABOLITE; ERYTHROMYCIN; GUAIFENESIN; NOVORYTHRO; TAMOXIFEN; UNCLASSIFIED DRUG; VERAPAMIL;

ACCURACY; ADULT; ARTICLE; CALIBRATION; CANCER PATIENT; CONTROLLED STUDY; DRUG DETERMINATION; DRUG URINE LEVEL; ENZYME ASSAY; FEMALE; FLUORESCENCE; FRUIT JUICE; GLIOMA; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PHENOTYPE; PRIORITY JOURNAL; SOLID PHASE EXTRACTION; TECHNIQUE;

EID: 0029965231     PISSN: 15726495     EISSN: None     Source Type: Journal    
DOI: 10.1016/0378-4347(95)00574-9     Document Type: Article

References (66)

1. F.J. Gonzalez and J.R. Idle, Clin. Pharmacokin., 26 (1994) 59.
2. A.K. Daly, S. Cholerton, W. Gregory and J.R. Idle, Pharmacol. Ther., 57 (1993) 129.
3. B.G. Katzung and A.J. Trevor, Pharmacology, Fourth Edition, Appleton and Lange, Norwalk, CT, 1995, pp. 408-411.
4. D.V. Parke and C. Ioannides, Annu. Rev. Nutr., 1 (1981) 207.
5. B.L. Lee, D. Wong, N.L. Benowitz and P.M. Sullam, Clin. Pharmacol. Ther., 53 (1993) 529.
6. C. Delomenie, D.M. Grant, P. Mathelier-Fusade, C. Jacomet, F. Leynadier, E. Jacqz-Aigrain, W. Rozenbaum, R. Krishnamoorthy and J.M. Dupret, Br. J. Clin. Pharmacol., 38 (1994) 38.
7. W. Kalow and B.-K. Tang, Clin. Pharmacol. Ther., 53 (1993) 503.
8. W.E. Evans, M.V. Relling, W.P. Petros, W.H. Meyer, J. Mirro and W.R. Crom, Clin. Pharmacol. Ther., 45 (1989) 568.
9. F.P. Guengerich and T. Shimada, Chem. Res. Toxicol., 4 (1991) 391.
10. D.R. Krishna and U. Klotz, Clin. Pharmacokin., 26 (1994) 144.
11. F.P. Guengerich, Chem. Res. Toxicol., 3 (1990) 363.
12. T. Aoyama, S. Yamano, D.J. Waxman, U.A. Meyer, V. Fisher, R. Tyndale, T. Inaba, W. Kalow, H.V. Gelboin and F.J. Gonzalez, J. Biol. Chem., 264 (1989) 10388.
13. T. Aoyama, S. Yamano, P.S. Guzelian, H.V. Gelboin and F.J. Gonzalez, Proc. Natl. Acad. Sci. (USA), 87 (1990) 4790.
14. S.A. Wrighton, W.R. Brian, M.A. Sari, M. Iwasaki, F.P. Guengerich, J.L. Raucy, D.T. Molowa and M. Vandenbranden, Mol. Pharmacol., 38 (1990) 207.
15. P. Dayer, T. Leemann and R. Striberni, Clin. Pharmacol. Ther., 45 (1989) 34.
16. M.G. Ladona, B. Lindstrom, C. Thyr, P. Dun-Ren and A. Rane, Br. J. Clin. Pharmacol., 32 (1991) 295.
17. E. Jacqz-Aigrain and T. Cresteil, Dev. Pharmacol. Ther., 18 (1992) 161.
18. E. Jacqz-Aigrain, C. Funck-Brentano and T. Cresteil, Pharmacogen., 3 (1993) 197.
19. J.C. Gorski, D.R. Jones, S.A. Wrighton and S.D. Hall, Biochem. Pharmacol., 48 (1994) 173.
20. N.L. Kerry, A.A. Somogyi, F. Bochner and G. Mikus, Br. J. Clin. Pharmacol., 38 (1994) 243.
21. M. Eichelbaum, N. Spannbrucker, B. Steincke and H.J. Dengler, Eur. J. Pharmacol., 16 (1979) 183.
22. L. Bertlisson, Y-Q. Lou, Y.-L. Du, Y. Liu, T.-Y. Kuang, X.-M. Liao, K.-Y. Wang, J. Reviriego, L. Iselius and F. Sjoqvist, Clin. Pharmacol. Ther., 51 (1992) 388.
23. E. Jacqz, H. Dulac and H. Mathieu, Eur. J. Clin. Pharmacol., 35 (1988) 167.
24. M.V. Relling, J. Cherrie, M.J. Schell, W.P. Petros, W.H. Meyer and W.E. Evans, Clin. Pharmacol. Ther., 50 (1991) 308.
25. B. Calesnick and J.A. Christensen, Clin. Pharmacol. Ther., 8 (1967) 374.
26. R.J. Guttendorf, P.J. Wedlund, J. Blake and S.-L. Chang, Ther. Drug Monit., 10 (1988) 490.
27. Y.H. Park, M.P. Kullberg and O.N. Hinsvark, J. Pharm. Sci., 73 (1984) 24.
28. M. Wenk, L. Todesco, B. Keller and F. Follath, J. Pharm. Biomed. Anal., 9 (1991) 341.
29. K. Fried and I.W. Wainer, J. Chromatogr. B, 655 (1994) 261.
30. A. Shibukawa and I.W. Wainer, J. Chromatogr., 574 (1992) 85
31. M. Gibaldi and D. Perrier, Pharmacokinetics, 2nd ed., Vol. 15, Marcel Dekker, New York, NY, 1982.
32. Y.W. Lam and S.Y. Rodriguez, Ther. Drug Monit., 15 (1993) 300.
33. E. Jacqz-Aigrain, Y. Menard, M. Popon and H. Mathieu, J. Chromatogr., 495 (1989) 361.
34. B. Schmid, J. Bircher, R. Preisig and A. Kupfer, Clin. Pharmacol. Ther., 38 (1985) 618.
35. F.P. Guengerich and D.H. Kim, Carcinogenesis, 11 (1990) 2275.
36. D.G. Bailey, J.D. Spence, C. Munoz and J.M.O. Arnold, Lancet, 337 (1991) 268.
37. M.P. Ducharme, L.H. Warbasse and D.J. Edwards, Clin. Pharmacol. Ther., 57 (1995) 485.
38. P. Periti, T. Mazzei, E. Mini and A. Novelli, Clin. Pharmacokin., 23 (1992) 106.
39. K.T. Olkkola, K. Aranko, H. Luurila, A. Hiller, L. Saarnivaara, J.J. Himberg and P.J. Neuvonen, Clin. Pharmacol. Ther., 53 (1993) 298.
40. P.K. Honig, D.C. Wortham, K. Zamani and L.R. Cantilena, Drug Invest., 7 (1994) 148.
41. C. Mani, H.V. Gelboin, S.S. Park, R. Pearce, A. Parkinson and D. Kupfer, Drug Metab. Dis., 21 (1993) 645.
42. F. Jacolot, I. Simon, Y. Dreano, P. Beaune, C. Riche and F. Berthou, Biochem. Pharmacol., 41 (1991) 1911.
43. H.K. Kroemer, J.C. Gautier, P. Beaune, C. Henderson, C.R. Wolf and M. Eichelbaum, Arch. Pharmacol., 348 (1993) 332.
44. S. Jaruratanasirikul, A.D. Cooper and T.F. Blaschke, Drug Metab. Dis., 20 (1992) 379.
45. E.A. Blankson, S.W. Ellis, M.S. Lennard, G.T. Tucker and K. Rodgers, Biochem. Pharmacol., 42 (1991) S209.
46. M. Silvasti, P. Kartunen, H. Tukiainen, P. Kokkonen, U. Hanninen and S. Nykanen, Int. J. Pharmacol. Ther. Toxicol., 25 (1987) 493.
47. J.R. Woodworth, S.R.K. Dennis, L. Moore, J. Clin. Pharmacol., 27 (1987) 139.
48. R.J. Guttendorf, M. Britto, R.A. Blouin, T.S. Foster, W. John, K.A. Pittman and P.J. Wedlund, Br. J. Clin. Pharmacol., 29 (1990) 373.
49. M. Silvasti, P. Kartunen, P. Happonen, M. Mykkanen, T. Romppanen and H. Tikiainen, Int. J. Pharmacol. Ther. Toxicol., 28 (1990) 268.
50. M. Aylward, J. Maddock, D.E. Davies, D.A. Protheroe and T. Leideman, Eur. J. Resp. Dis., 65 (1984) 283.
51. D. Hollander, J. Pradas, R. Kaplan, H.L. McLeod, W.E. Evans and T.L. Munsat, Ann. Neurol., 36 (1994) 920.
52. M. Rowland and T.N. Tozer, Clinical Pharmacokinetics, 2nd ed., Lea and Febiger, Philadelphia, PA, 1989.
53. G. Pfaff, P. Briegel and I. Lampbrecht, Int. J. Pharm., 14 (1983) 173.
54. C. Funck-Brentano, G. Thomas, E. Jacqz-Aigrain, J.M. Poirier, T. Simon, G. Bereziat and P. Jaillon, J. Pharmacol. Exp. Ther., 263 (1992) 780.
55. D. Larrey, G. Amouyal, M. Tinel, P. Letteron, A. Berson, G. Labbe and D. Pessayre, Br. J. Clin. Pharmacol., 24 (1987) 676.
56. D. Larrey, A. Berson, F. Habersetzer, M. Tinel, A. Castot, G. Babany, P. Letteron, E. Freneaux, J. Loeper, P. Dansette and D. Pessayre, Hepatology, 10 (1989) 168.
57. M.J. Rider, N.H. Shear, A. Kanee, B.K. Tang and S.P. Spielberg, Clin. Pharmacol. Ther., 49 (1991) 13.
58. L. Gu, F.J. Gonzalez, W. Kalow and B.K. Tang, Pharmacogenetics, 2 (1992) 73.
59. W. Tassaneeyakul, D.J. Birkett, M.E. McManus, M.E. Veronese, T. Andersson, R.H. Tukey and J.O. Miners, Biochem. Pharmacol., 47 (1994) 1767.
60. W. Tassaneeyakul, Z. Mohamed, D.J. Birkett, M.E. McManus, M.E. Veronese, R.H. Turkey, L.C. Quattrochi, F.J. Gonzalez and J.O. Miners, Pharmacogenetics, 2 (1992) .173
61. P.B. Watkins, S.A. Murray, L.G. Winkelman, D.M. Heuman, S.A. Wrighton and P.S. Guzelian, J. Clin. Invest., 83 (1989) 688.
62. C.M. Fleming, R.A. Branch, G.R. Wilkinson and F.P. Guengerich, Mol. Pharmacol., 41 (1992) 975.
63. Y. Horsman, J.P. Desager and C. Harvengt, Pharmacol. Toxicol., 7 (1992) 258.
64. D.G. May, J.A. Porter, J.P. Utrecht, G.R. Wilkinson and R.A. Branch, Clin. Pharmacol. Ther., 48 (1990) 619.
65. M.T. Kinirons, Y. Krivoruk, G.R. Wilkinson and A.J.J. Wood, Clin. Pharmacol. Ther., 57 (1995) 186.
66. M.T. Kinirons, D. O'Shea, T.E. Downing, A.T. Fitzwilliam, L. Joellenbeck, J.D. Groopman, G.R. Wilkinson and A.J.J. Wood, Clin. Pharmacol. Ther., 54 (1993) 62.